Research Topics

Populations

Types of Research

Dataset

EPAR Technical Report #346
Publication Date: 04/23/2018
Type: Literature Review
Abstract

The private sector is the primary investor in health research and development (R&D) worldwide, with investment annual investment exceeding $150 billion, although only an estimated $5.9 billion is focused on diseases that primarily affect low and middle-income countries (LMICs) (West et al., 2017b). Pharmaceutical companies are the largest source of private spending on global health R&D focused on LMICs, providing $5.6 billion of the $5.9 billion in total private global health R&D per year. This report draws on 10-K forms filed by Pharmaceutical companies with the U.S. Securities and Exchange Commission (SEC) in the year 2016 to examine the evidence for five specific disincentives to private sector investment in drugs, vaccines and therapeutics for global health R&D: scientific uncertainty, weak policy environments, limited revenues and market uncertainty, high fixed costs for research and manufacturing, and imperfect markets. 10-K reports follow a standard format, including a business section and a risk section which include information on financial performance, investment options, lines of research, promising acquisitions and risk factors (scientific, market, and regulatory). As a result, these filings provide a valuable source of information for analyzing how private companies discuss risks and challenges as well as opportunities associated with global health R&D targeting LMICs.

EPAR Technical Report #223
Publication Date: 12/10/2012
Type: Literature Review
Abstract

Cassava is a tuber crop originating in South America and grown in tropical and subtropical areas throughout the world. Cassava use varies significantly by region. In Africa, cassava is primarily grown for food. In Asia, production is typically for industrial purposes, including ethanol, while in Latin America and the Caribbean it is commonly used in animal feed. Both roots and leaves are consumed, though most information on production focuses on roots. There are bitter and sweet varieties; bitter cassava has a high cyanide content and must be processed prior to consumption, while sweet varieties can be eaten directly. This report presents information about current production, constraints, and future potential of cassava. We discuss cassava’s importance in Africa, current worldwide production, projections for supply and demand, production constraints, and current policies affecting cassava production and trade. We include global information but focus on Africa, particularly Nigeria, Ghana, Uganda, and Tanzania.

EPAR Technical Report #199
Publication Date: 07/27/2012
Type: Literature Review
Abstract

Over the past 20 years, global wheat production and consumption have increased significantly. Production has increased 28%, or about 1.3% annually, and consumption has increased about 24%, or 1.1% annually. A small number of countries consistently account for over 90% of the export market, but the import market is more diversified and involves many more countries. Wheat is primarily used for food, seed, and industry; only 20% of wheat production is used for animal feed. This brief provides a global overview of the wheat value chain, but with specific attention to three focus countries: Ethiopia, India (specifically the Bihar region), and Bangladesh. While these three countries currently have a limited impact in the global wheat market, projections of wheat production and demand suggest that over the next 20 years demand in Bangladesh and Ethiopia will increasingly exceed supply, while India will become a net importer by 2030.